Products
Pre-made Besilesomab benchmark antibody (Radiolabelled antibody, anti-CEACAM8/NCA-95 therapeutic antibody, Anti-CD66b/CD67/CGM6 Antibody) for drug discovery and mechanism of action (MOA) research
Cat No.: GMP-Bios-INN-756
Pre-made Besilesomab benchmark antibody (Radiolabelled antibody, anti-CEACAM8/NCA-95 therapeutic antibody, Anti-CD66b/CD67/CGM6 Antibody) is a biosimilar expressed by mammalian cell line as a benchmark reference therapeutic antibody for biological drug disovery items including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Besilesomab (trade name Scintimun) is a mouse monoclonal antibody labelled with the radioactive isotope technetium-99m. It is used to detect inflammatory lesions and metastases.[1] It binds to an immunoglobulin, IgG1 isotype. SCINTIMUN has been used since 1992 mainly in Hungary, Czech Republic, and Switzerland on the basis of local marketing authorizations, and in Germany (on the basis of individual prescription). Between 1992 and 2009, an estimated 90,000 patients has been studied. In 2009, the EMEA has approved SCINTIMUN for marketing in all European countries.[
Order information
* GeneMedi provides NON-PROFIT PRICE to support Academic research. Please click inquiry for product quotation. → Inquiry
| Catalog No. | Package | Price(In USD) | Qty (Quantity) | Sum(In USD) |
|---|---|---|---|---|
| GMP-Bios-INN-756-1mg | 1mg | 3090 | ||
| GMP-Bios-INN-756-10mg | 10mg | Inquiry | ||
| GMP-Bios-INN-756-100mg | 100mg | Inquiry | ||
| GMP-Bios-INN-756-xmg | ≥100mg | Inquiry | ||
| Shipping Cost: | 760.00 | |||
| Total: | ||||
Description
| Products Name (INN Index) | Pre-Made Besilesomab Biosimilar, Radiolabelled Antibody, Anti-Ceacam8/NCA-95 Antibody: Anti-CD66b/CD67/CGM6 therapeutic antibody | Besilesomab |
| INN Name | Besilesomab | |
| Target | CEACAM8 | |
| Format | Radiolabelled antibody | |
| Derivation | Mus musculus | |
| Species Reactivity | human | |
| CH1 Isotype | IgG1 - kappa | |
| VD LC | IgG1 - kappa | |
| Highest_Clin_Trial (Jan '20) | ||
| Est. Status | ||
| 100% SI Structure | ||
| 99% SI Structure | ||
| 95-98% SI Structure | ||
| Year Proposed | ||
| Year Recommended | ||
| Companies | Iba Molecular Imaging (Louvain- la-Neuve Belgium) | |
| Conditions Approved | ||
| Conditions Active | ||
| Conditions Discontinued | ||
| Development Tech | 0 |
- GENEMEDI
- Email: [email protected] [email protected]
- Telephone: +86-21-50478399 Fax: 86-21-50478399
- Privacy Policy
- TECHNICAL SUPPORT
- Product FAQs
- Technical manuals
- Publications
- Email: [email protected]
Facebook
LinkedIn
Twitter
